The Cremins lab investigates the epigenetic mechanisms regulating development and function of the mammalian central nervous system. We map and analyze neuronal epigenomes in three-dimensions using quantitative, genome-wide technologies. We also perturb epigenomes by employing state-of-the art genetic engineering strategies (e.g. CRISPR/Cas9, optoepigenetics). To test our hypotheses, we primarily use embryonic and induced pluripotent stem cell models of neuronal differentiation and disease. Our long-term goal is to discover how genome architecture controls genome function, applying this to study fundamental mechanisms controlling neuronal phenotype and, by extension, the onset and progression of neurodegenerative and neurodevelopmental disease states.

Jun 28, 2019

Jon Beagan presents his work at the Neuroepigenetics interest group in the Epigenetics Institute.

Jun 13, 2019

Linda Zhou presents her work for the Epigenetics Institute monthly seminar series.

Jun 4, 2019

Jennifer presents the lab’s work at the Evolution and 
Function of higher-order chromosomes meeting at the Institut Pasteur in 
Paris France.

Jun 3, 2019

Jennifer presents the lab’s work at the European Molecular 
Biology Laboratory in Heidelberg, Germany.

May 28, 2019

Ji Hun Kim travels to Greece to present a podium talk on his 
Light Activated Dynamic Looping technology. Congratulations Ji Hun!

May 8, 2019

Jennifer presents the lab’s work at the University of Chicago.

logos  

 

Our work is supported by the New York Stem Cell Foundation, the Alfred P. Sloan Foundation, the National Science Foundation, an NIH New Innovator Award through the National Institute of Mental Health and the NIH 4D Nucleome Common Fund Initiative.